細(xì)胞周期后期促進(jìn)蛋白亞基11抗體 返回列表頁

英文名稱 APC11
中文名稱 細(xì)胞周期后期促進(jìn)蛋白亞基11抗體
別    名 ANAPC 11; ANAPC11; Anaphase promoting complex subunit 11; Anaphase promoting complex subunit 11 homolog (yeast); Anaphase promoting complex subunit 11 homolog; Anaphase-promoting complex subunit 11; Apc 11; Apc 11p; APC11 anaphase promoting complex subunit 11 homolog (yeast); APC11 anaphase promoting complex subunit 11 homolog; APC11; APC11_HUMAN; Apc11p; Cyclosome subunit 11; Hepatocellular carcinoma associated RING finger protein; Hepatocellular carcinoma-associated RING finger protein; HSPC 214; HSPC214; MGC882; Yeast APC 11 homolog; Yeast APC11 homolog.
細(xì)胞周期后期促進(jìn)蛋白亞基11抗體  
說 明 書 0.2ml  
研究領(lǐng)域 細(xì)胞生物  細(xì)胞周期蛋白  泛素  
抗體來源 Rabbit
克隆類型 Polyclonal
交叉反應(yīng) Human, Mouse, Rat, Dog, Pig, Sheep, 
產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 （石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量 10kDa
細(xì)胞定位 細(xì)胞核 細(xì)胞漿 
性    狀 Lyophilized or Liquid
濃    度 1mg/1ml
免 疫 原 KLH conjugated synthetic peptide derived from human APC11
亞    型 IgG
純化方法 affinity purified by Protein A
儲 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
產(chǎn)品介紹 background:
Comprising more than ten subunits, the anaphase-promoting complex (APC) acts in a cell-cycle dependent manner to promote the separation of sister chromatids during the transition between metaphase and anaphase in mitosis. APC, or cyclosome, accomplishes this progression through the ubiquitination of mitotic cyclins and other regulatory proteins that are targeted for destruction during cell division. APC is phosphorylated, and thus activated, by protein kinases Cdk1/cyclin B and polo-like kinase (Plk). APC is under tight control by a number of regulatory factors, including CDC20, CDH1 and MAD2. Specifically, CDC20 and CDH1 directly bind to APC and activates APC’s cyclin-ubiquitination activity. In contrast, MAD2 inhibits APC by forming a ternary complex with CDC20 and APC; thus preventing APC activation. APC11 is a RING-H2 finger protein that allows for the synthesis of multiubiquitin chains in the presence of Ubiquitin carrier protein 4 (Ubc4) and ubiquitin conjugating enzyme (E2). In addition, a heterodimeric complex of either Ubc4 or UbcH10 with APC11 and APC2 catalyzes the ubiquitination of human securin and cyclin B1.

Function:
Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle. The APC/C complex acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of 'Lys-11'-linked polyubiquitin chains and, to a lower extent, the formation of 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains. May recruit the E2 ubiquitin-conjugating enzymes to the complex.

Subunit:
The APC/C is composed of at least 12 subunits. Interacts with the cullin domain of ANAPC2. Interacts with UBE2D2.

Subcellular Location:
Cytoplasm. Nucleus.

Tissue Specificity:
Expressed at high levels in skeletal muscle and heart; in moderate levels in brain, kidney, and liver; and at low levels in colon, thymus, spleen, small intestine, placenta, lung and peripheral blood leukocyte.

Post-translational modifications:
Auto-ubiquitinated.

Similarity:
Belongs to the RING-box family.
Contains 1 RING-type zinc finger.

Database links:
UniProtKB/Swiss-Prot: Q9NYG5.1

Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.xy-0134R Nogo-A軸索過度生長抑制因子-A抗體
xy-0156R nNos/一氧化氮合成酶-1抗體（神經(jīng)型）
xy-0163R eNOS一氧化氮合成酶-3（內(nèi)皮型）抗體
xy-0181R Nociceptin receptor孤菲肽受體/痛敏肽受體抗體
xy-0448R NIS鈉碘轉(zhuǎn)運(yùn)體蛋白抗體
xy-0064R Neurokinin 1 ReceptorP物質(zhì)受體抗體
xy-0166R Neurokin B receptor神經(jīng)激肽B受體抗體
xy-0688R Nm23腫瘤轉(zhuǎn)移抑制基因抗體
xy-1066R NME1腫瘤抑制基因抗體
xy-1073R Nm23-H2腫瘤抑制基因抗體
xy-0075R Nociceptin孤菲肽/痛敏肽抗體
xy-0129R Nogo R軸索過度生長抑制因子受體/Nogo受體抗體
xy-12151R NAV3神經(jīng)元引導(dǎo)蛋白3抗體
xy-10027R NCR1細(xì)胞毒性受體NK-p46抗體
xy-12146R Neurabin 2神經(jīng)組織特異性F肌動(dòng)蛋白結(jié)合蛋白2抗體
xy-9320R NYS48NYS48蛋白抗體
xy-9331R NHLRC1肌痙攣性癲癇病相關(guān)EPM2蛋白抗體
xy-9332R NHLRC2非霍奇金淋巴瘤重復(fù)蛋白2抗體
xy-0323R NMDAR2C谷氨酸受體2C抗體（N端）
xy-6855R NALP4癌/睪丸抗原58抗體
xy-9333R NHLRC3非霍奇金淋巴瘤重復(fù)蛋白3抗體
xy-9710R NOP2增殖相關(guān)核仁抗原抗體
xy-6864R NALP12NALP12抗體
xy-6865R NALP6富含亮氨酸重復(fù)結(jié)構(gòu)域蛋白6抗體